Anti-Phospholipid Screen IgG/IgM

Anti-Phospholipid Screen IgG/IgM is an ELISA screening test for the quantitative determination of IgG and IgM antibodies against cardiolipin, phosphatidyl serine, phosphatidyl inositol, phosphatidic acid, and cofactor beta-2-glycoprotein I in human serum or plasma.
This test is an outstanding tool for the serological detection of primary and secondary antiphospholipid syndrome.

The combined detection of four “phospholipid antibodies” lends this test particularly high clinical sensitivity. ORGENTEC’s test systems for the isolated detection of the individual phospholipid autoantibodies, the Anti-beta-2-glyoprotein-I test, or the ThromboCombo ELISA can subsequently be used for the differentiated quantitative determination of the autoantibodies.


Product Number ORG 529
Tests12 x 8 tests
CalibrationHarris sera, IRP 97/656 (IgG), HCAL (IgG) / EY2C9 (IgM)
RangeIgG: 0 - 100 GPL-U/ml; IgM: 0 - 100 MPL-U/ml
Cut-offIgG: 10 GPL-U/ml; IgM: 10 MPL-U/ml
Coating cardiolipin (cofactor: beta-2-GPI), phosphatidic acid, phosphatidyl inositol, phosphatidyl serine


Instruction for Use
Safety Data Sheet

Document Archive
Instruction for Use Revision 4. Earlier versions and additional languages can be found in the document archive.

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.